Vermillion, Inc.: FDA filings under this applicant name

FDA lists 1 510(k) clearance under the applicant name “Vermillion, Inc.” (first 2016, latest 2016), plus 1 De Novo decision, across 1 product code in 1 review panel. Median 510(k) review time under this name: 375 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
20161375
20170—
20180—
20190—
20200—
20210—
20220—
20230—
20240—
20250—
20260—

Top product codes

Product codeDeviceSubmissions510(k) clearances
ONXOvarian Adnexal Mass Assessment Score Test System21

Review panels

Most recent Vermillion, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K150588OVA1 Next GenerationONX2016-03-18375

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN090004De NovoOvarian Adnexal Mass Assessment Score Test System2009-09-11

Recalls

openFDA lists no recalls under a recalling firm named Vermillion, Inc..

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Frequently asked questions

How many FDA 510(k) clearances are listed under Vermillion, Inc.?

FDA lists 1 510(k) clearance under the applicant name “Vermillion, Inc.” (first 2016, latest 2016), plus 1 De Novo decision, across 1 product code in 1 review panel. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by Vermillion, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name Vermillion, Inc. is 375 days.

Which FDA product codes appear under Vermillion, Inc.?

The most frequent FDA product codes under this applicant name are ONX (Ovarian Adnexal Mass Assessment Score Test System, 2).

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Each page covers one FDA applicant name, with punctuation and legal suffixes removed; filings under other names are not included. Review days run from FDA receipt to decision. Not regulatory advice. Report an error in this data.

All FDA device companies · FDA product code lookup